Quick Answer
Crinetics Pharmaceuticals, Inc. reported Total Assets of $1.13 billion for fiscal year 2025.
Crinetics Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.13B | -21.5% |
| 2024 | $1.43B | +125.8% |
| 2023 | $635.35M | +80.4% |
| 2022 | $352.18M | +0.3% |
| 2021 | $351.01M | +91.3% |
| 2020 | $183.44M | +40.7% |
| 2019 | $130.38M | -23.9% |
| 2018 | $171.41M | +999.0% |
| 2017 | $15.60M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.20B | +27.6% | -7.3% |
| June 30, 2025 | $1.29B | +37.8% | -5.3% |
| March 31, 2025 | $1.36B | +39.2% | -5.1% |
| December 31, 2024 | $1.43B | +125.8% | +53.0% |
| September 30, 2024 | $937.37M | +46.1% | +0.2% |
| June 30, 2024 | $935.53M | +219.0% | -4.4% |
| March 31, 2024 | $978.15M | +211.5% | +54.0% |
| December 31, 2023 | $635.35M | +80.4% | -1.0% |
- Crinetics Pharmaceuticals, Inc. showed a decrease of -21.5% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Crinetics Pharmaceuticals, Inc.’s total assets has grown by 7120.5% (from $15.60 million to $1.13 billion).
- The most recent figure is from Crinetics Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: